Duration of Antiplatelet Therapy After ACS in Patients on Long-Term Anticoagulation

🩸 Duration of Antiplatelet Therapy After ACS in Patients on Long-Term Anticoagulation

This infographic summarizes expert guidance on managing antiplatelet therapy in patients with atrial fibrillation who are already on long-term oral anticoagulation and present with an acute coronary syndrome. It outlines how therapy should be tailored based on the timing of the acute event, whether PCI was performed, and the patient’s thrombotic and bleeding risks. Key takeaways include prioritizing DOAC over warfarin, favoring clopidogrel as the P2Y12 inhibitor, and minimizing triple therapy duration. The overall message: balance is key—optimize ischemic protection while reducing bleeding risk.

Created by Dr. Yong Hao Yeo

Reviewed by Dr. Claire Cambron

Reviewed by Dr. Sukriti Banthiya


CardioNerds Infographics

Explore our comprehensive collection of infographics, categorized by cardiovascular topics such as heart failure and transplantation, arrhythmias and electrophysiology, cardio-obstetrics, cardiovascular imaging, congenital heart disease, prevention, coronary artery disease, critical care, hypertension, pericardial disease, pulmonary hypertension, valvular heart disease, vascular disease, women’s cardiovascular health, diversity, inclusion, and more!

Feel free to download and share these visuals in presentations or on social media. Please use the infographics as provided—without altering or cropping out the creators’ credit.

For even more learning, explore the CardioNerds Tweetorial Page, featuring a curated collection of educational tweetorials!